Boxer Capital, LLC’s Akero Therapeutics Inc Com Position
Does Boxer Capital, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 1.68M shares worth $48M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$48M
Q3 2024
Shares
1.68M
% of Portfolio
+2.36%
Quarters Held
22
position exited
Position History AKRO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 1.68M | $48M | +2.36% |
| Q2 2024 | 1.68M | $39M | +2.07% |
| Q1 2024 | 1.68M | $42M | +2.09% |
| Q4 2023 | 1.68M | $39M | +1.95% |
| Q3 2023 | 1.68M | $85M | +4.51% |
| Q2 2023 | 1.68M | $78,287 | +3.63% |
| Q1 2023 | 831.5K | $31,813 | +1.56% |
| Q4 2022 | 831.5K | $46M | +2.40% |
| Q3 2022 | 831.5K | $28M | +1.59% |
| Q2 2022 | 831.5K | $8M | +0.50% |
| Q1 2022 | 831.5K | $12M | +0.61% |
| Q4 2021 | 831.5K | $18M | +0.68% |
| Q3 2021 | 831.5K | $19M | +0.65% |
| Q2 2021 | 831.5K | $21M | +0.73% |
| Q1 2021 | 831.5K | $24M | +0.82% |
| Q4 2020 | 831.5K | $21M | +0.69% |
| Q3 2020 | 831.5K | $26M | +0.88% |
| Q2 2020 | 416.5K | $10M | +0.46% |
| Q1 2020 | 416.5K | $9M | +0.60% |
| Q4 2019 | 482.5K | $11M | +0.61% |
| Q3 2019 | 482.5K | $11M | +0.80% |
| Q2 2019 | 396.7K | $8M | +0.65% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of AKRO.